🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

ABVC ABVC

Company Profile ↓
$1.01
-68.44% 1Y
Mkt Cap$25.30M
P/E-2.59
P/B2.28
52W High$3.30
52W Low$0.91
Book Value$0.44
EPS (TTM)$-0.39

Company Overview

ABVC (ABVC) is a publicly traded company listed on with a market capitalization of $25.30M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.31.

Recent Developments

  • Trailing 12 Months Year-on-year growth — revenue -100.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-
1 Year:-100.00%

Stock Price Performance

1 Year:-68.44%
6 Months:-46.84%
3 Months:-1.94%
1 Month:-50.00%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 4% of range
$0.91 $3.30
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)37.62 · Neutral
Price Performance
1M-50.00%
3M-1.94%
6M-46.84%
1Y-68.44%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 69.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-2.59
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.44
Price to Book
2.28
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-100.00%
Earnings (YoY)
-

Profitability & Returns

ROCE
-48.00%
ROE
-71.17%
ROA
-37.55%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.06
EPS (TTM)
$-0.39

Balance Sheet & Liquidity

Debt/Equity
0.31
Quick Ratio
0.41
Current Ratio
0.41
Debt
$3.47M
Total Assets
$19.73M
Current Assets
$648.85K
Working Capital
$-3.66M

Ownership

Promoter Holding
18.57%
Chg in Prom Hold
-
FII / Inst Holding
3.14%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$0
EBITDA
$-7.43M
Free Cash Flow
$-2.99M
Operating Cash Flow
$-2.99M
Shares Outstanding
25.05M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2013Mar 2014Jun 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Dec 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 00002.26K0----70.00K-90.00K--3.23K747212.24K191.78K197.73K78.79K226.51K115.55K263.15K31.44K99.00K25.66K312.86K42.27K128.27K6.11K15.88K1.21K117.14K389.28K000-795.95K0
Cost of Revenue -----------------------------------00000
Gross Profit -00-1.96K0---32-70.00K-90.00K--910210210.74K178.43K194.94K74.83K222.28K106.93K261.90K30.80K98.61K23.76K304.49K31.53K68.04K-66.87K-13.73K928116.95K388.98K000-795.95K0
Operating Expenses -----------------------------------693.00K2.29M1.96M2.20M1.57M
Operating Income -10-30-30-1.03K1.12K-1.50K-315.60K-3.50M-6.61M-289.10K-140.39K-236.84K-189.48K-3.36M-674.20K-524.43K-396.29K-730.57K-488.81K-1.12M-1.17M-1.19M-1.29M-1.25M-2.04M-1.97M-6.22M-2.05M-3.72M-1.91M-2.19M-2.15M-2.84M-860.11K-302.32K-693.00K-2.29M-1.96M-2.99M-1.57M
EBITDA ------------------------------------607.27K-2.10M-1.96M-3.57M-1.55M
Interest Expense -----------------------------------222.97K129.41K30.96K32.55K49.38K
Pretax Income ------------------------------------944.19K-2.31M-2.08M-3.81M-1.69M
Tax Provision -----------------------------------023.63K52700
Net Income -10-30-30-1.03K1.12K-1.50K-315.60K-3.50M-6.61M-293.24K-140.34K-256.67K-217.88K-3.39M-713.62K-736.04K-687.30K-873.32K-614.45K-1.33M-1.31M-2.18M-2.13M-1.20M-1.97M-1.81M-6.00M-1.86M-3.70M-1.82M-2.26M-3.32M-2.83M-942.34K-394.77K-842.08K-2.26M-2.04M-3.56M-1.56M
Diluted EPS ------0.00-0.02--0.000.000.00-0.02-0.05-0.050.00-0.05-0.03--0.06-0.09-0.09-0.05-0.08-0.07-0.20-0.59-1.14-0.55-0.68-0.82-0.29-0.08-0.03-0.06-0.13-0.09--0.06
R&D Expense -------3.50M6.50M-25.20K25.15K17.50K3.08M248.11K56.70K54.51K421.96K87.77K269.24K92.79K139.08K134.50K121.31K358.88K263.42K359.40K532.78K305.48K334.98K514.44K141.31K69.07K40.40K37.83K28.86K33.28K29.89K-33.10K

Profit & Loss (Annual)

Figures in USD.

Metric Sep 2011Sep 2012Sep 2013Sep 2014Sep 2015Dec 2015Sep 2016Sep 2017Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 3.19K5.71K7.79K03.36K50.00M---6.96K701.72K483.05K-969.78K152.43K509.59K0
Cost of Revenue -------------286.42K302.04K7630
Gross Profit ---02.84K--32---178.32K681.58K464.33K-683.37K-149.61K508.83K0
Operating Expenses -------------15.80M6.62M5.21M7.15M
Operating Income -1.89M-1.14M-177.26K----11.00M-4.00M-4.14M-2.78M-3.46M-8.51M--15.11M-6.77M-4.71M-7.15M
EBITDA --------------15.20M-6.33M-4.34M-7.43M
Interest Expense -------------293.97K1.31M825.90K415.89K
Pretax Income --------------15.51M-8.02M-5.37M-8.35M
Tax Provision -------------797.78K256.01K-110.54K24.15K
Net Income -1.22M-1.07M-226.35K-70-32.28K--11.01M-4.07M-4.24M-6.06M-3.93M-10.59M--16.42M-7.79M-4.90M-7.91M
Diluted EPS -------0.06-0.02-0.02-0.02--0.50--5.20-1.80-0.42-0.39
R&D Expense ------10.00M3.15M3.17M988.72K1.05M549.66K1.00M2.69M1.06M179.27K121.08K

Balance Sheet (Annual)

Figures in USD.

Metric Sep 2010Sep 2011Sep 2012Sep 2013Sep 2014Jul 2015Sep 2015Sep 2016Dec 2016Sep 2017Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -369.40K302.31K231.97K65.39K-1.00M177.35K-2.75M2.64M5.94M6.93M11.61M-9.58M7.78M7.54M21.06M
Current Assets ---------------2.99M1.66M2.18M2.50M
Cash & Equivalents 2.81K71.78K13.39K6180-994.83K173.54K18.64K204.85K93.33K226.69K144.29K4.27M-85.27K60.16K248.38K681.48K
Inventory --------------25.98K0---
Receivables --------------280.69K98.33K1.53K0-
Total Liabilities ----34.03K-369.10K6.56M-4.15M4.40M11.28M7.05M8.94M-6.34M6.53M6.82M7.76M
Current Liabilities -1.83M1.95M2.11M34.03K-----4.40M10.99M6.81M4.84M-5.54M6.10M6.56M6.16M
Long Term Debt -------------------
Total Debt ---------------3.05M2.60M2.43M3.47M
Total Equity -2.99M-1.46M-1.64M-1.88M31.36K897.00K633.36K-6.38M-6.52M-1.39M-1.76M-5.66M-150.96K3.44M-3.10M1.55M1.23M11.11M
Shares Outstanding ---------------3.31M7.94M13.87M25.05M

Cash Flows (Annual)

Figures in USD.

Metric Sep 2011Sep 2012Sep 2013Sep 2014Sep 2015Sep 2016Sep 2017Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -1.59M-915.12K-37.77K1.17K3.36K-3.47M-1.60M-1.49M-900.53K-3.13M-4.56M--7.40M-4.19M-1.81M-2.99M
Investing Cash Flow -38.74K-19.55K000----156.37K-35.30K-225.43K--1.72M-360.19K0-1.21M
Financing Cash Flow 1.70M876.27K25.00K002.65M1.63M1.56M896.86K3.09M9.57M-4.01M3.87M1.98M4.64M
Capital Expenditure -29.82K-350-0---------17.50K-119.69K-21.20K--
Free Cash Flow -1.62M-915.47K-37.77K----------7.52M-4.21M-1.81M-2.99M
Net Change in Cash -------------5.11M-677.07K171.62K442.91K

Ratios (Annual)

Figures in %.

Metric Sep 2011Sep 2012Sep 2013Sep 2014Sep 2015Dec 2015Sep 2016Sep 2017Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ----84.5%-----2,563.6%97.1%96.1%-70.5%-98.1%99.9%-
Operating Margin % -59,180.7%-20,004.3%-2,276.3%-------40,031.1%-492.9%-1,760.9%--1,558.5%-4,439.2%-923.3%-
Net Margin % -38,202.2%-18,718.6%-2,906.8%--960.7%-----87,184.2%-560.5%-2,193.1%--1,693.5%-5,109.3%-962.1%-
ROE % 83.3%65.1%12.0%-0.2%-5.1%-172.6%292.3%241.5%107.2%2,605.4%-308.1%--530.0%-501.1%-399.9%-71.2%
ROCE % 129.0%69.5%9.4%-----235.6%55.2%-3,044.2%-125.8%--374.5%-402.2%-478.9%-48.0%

Shareholding Pattern

Insiders
18.57%
Institutions
3.14%
Public Float
3.86%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ABVC

Google News Mon, 03 Aug 2026

Microsoft warns hackers are targeting hotel Wi-Fi networks: What to know, how to protect yourself - ABC News - Breaking News, Latest News and Videos

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPd0xINjUtcldjbk81TVlfOHdfSHJjT0FvNmhQV1c1djJqdUVUNnF6WmFhZ1JQaFRfUmRFZVFTaDkwQlAybFRsNGxJMUFBM3cxM2VBX1VsZWhjTDhBdXJMM2lVN0hxTk9YY2RGM3dmNWptTlU0S01FeDVreTFTMHNHc0tYQ1ZSak1vSWFabD…

Google News ue, 04 Aug 2026

ABVC postpones BioKey share distribution; ratio, record date unchanged - TradingView

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5HLUFmbFpTaEZuVDdHeTZybUltTlVXbktLNkYwTE1HZVRiVDh2aUduSFdxNlpNYlFhQTJVN1FFVE5kTXcteks5cUsxSW8wVWNWMEpVZXNHUzBDdVcxQlJEQW40Y0VUMWw4bFo3Rg?oc=5" target="_blank">ABVC postpones BioKey…

Google News ue, 28 Jul 2026

ABVC BioPharma (ABVC) to vote on 2026 equity plan and Taiwan land-share issuance - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPeUdYSWVjLUM0TjlOaTZ4aHc2T291U3BhS2p5czZOY2VxOVc5bmcxRFh3WENYZm9YUmF4UTVzV1c5eXpZWjA3Z0N4Wk15SDgyUDBjRzUxQ1pVYUJtc0tGekl6WVNxdzBZQ3l4Rk5IaWxLbTF0R1lxYjBET21lajQ1MmxKZTNnNFJCdEEzNj…

Google News ue, 23 Jun 2026

ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc. Through Dividend Distribution of BioKey Shares to ABVC Shareholders - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNbTgwMkFhaHBTZ3FMWklaaW1NWk9jOHViMFZSdEVBWEJQVWJySjN5VDl5eG1JQUhRWDRFdkVhRlE5dWRzazg4cHAtc19GMER4UWVkN3F5V1lnV2w0cW9EMW10cldyR1ZkdEZjWGxqMlJzYk9HSWhUckZzUFBpeGF1Y0FtdS15RXl2MWwtMT…

Google News Sun, 02 Aug 2026

Global shockwaves as South Korea's crash rattles markets - ABC News & Headlines – Australian Broadcasting Corporation

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNUldRMFhxeFhIZkZLWDRVVk1WT3BCdTZ0UnA1dThlWTFvV2g0YzYtVDFpdUJvbTI2Tk1qNENsUWVQWVMwRlhDWDFTMFI4SXJlM2szTjd0ZXJEblFYQTlQNldyamlaSVRjVEF4TjJacGpmLU9NM3JYOTNSSkFFY1lhdmFkdkRidWttZUNRa1…

Google News Fri, 31 Jul 2026

ABVC|ABVC Biopharma Inc|Price:1.046|Chg%:+0.036 - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFA5VUZKa1VXU2x0dVk0aVhLUjlfeE8xUllSWXNVbGRtb25VakxidnUyOTJVWVMtcUpLUm5seDhNb3VBTnRHQTMwdEp3RUY2WU82V01LcFRFanNMeUczT3MtVjlheGFPX2N6VXBnbm5R?oc=5" target="_blank">ABVC|ABVC Biopharma…

ABVC — Frequently Asked Questions

What is the current share price of ABVC?

As of 2026-08-05 17:25 PDT, ABVC trades at $1.01 on NASDAQ/NYSE. Its 52-week range is $0.91 to $3.30.

What is the market capitalisation of ABVC?

ABVC has a market capitalisation of $25.30M on NASDAQ/NYSE.

What is the P/E ratio of ABVC?

ABVC trades at a trailing price-to-earnings (P/E) ratio of -2.59. Its price-to-book (P/B) ratio is 2.28.

What is the return on equity (ROE) of ABVC?

ABVC has a return on equity (ROE) of -71.17%. Its return on capital employed (ROCE) is -48.00%.

Is ABVC a good stock to buy?

This page provides a data-driven analysis of ABVC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space